Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials

NCT06093594 is registered in ClinicalTrials.gov with Power Life Sciences Inc. as lead sponsor.

NCT NCT06093594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials
Lead sponsor
Power Life Sciences Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
November 30, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv melanoma